REQUEST A DEMO
Total
USD $0.00
Search more companies

Optipharm Co.,Ltd (South Korea)

Main Activities: Medicinal and Botanical Manufacturing
Full name: Optipharm Co.,Ltd Profile Updated: July 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

The Company is a Korea-based company mainly engaged in the production and sale of veterinary drugs. The Company operates its business through two segments. The Sale Business segment is involved in the provision of livestock disease appraisal services, animal drug distribution, and the manufacturing and sale of feed additives. The New Business segment is engaged in research and development of heterologous organisms, virus like particle (VLP) vaccines, and human diagnostic kits. Heterogeneous organ products include heterologous skin, xenogeneic islets and xenogeneic corneal products, among others. VLP vaccines include VLP based animal combined vaccines and human papillomavirus (HPV) vaccines for the human body, among others. Human body diagnostic kits include human breast cancer and cervical cancer diagnostic reagents, among others. The Company distributes its products within the domestic market and to overseas markets. The Company was established on July 27, 2000. The Company share was listed on the Korea Securities Dealers Automated Quotation System ( KOSDAQ ) on October 26, 2018.

Headquarters
63, Oseongsaengmyeong 6-Ro, Osong-Eup, Heungdeok-Gu, Cheongju-Si, Chungcheongbuk-Do
Cheongju; Chungcheongbuk;

Contact Details: Purchase the Optipharm Co.,Ltd report to view the information.

Website: http://www.optipharm.co.kr

Basic Information
Total Employees:
Purchase the Optipharm Co.,Ltd report to view the information.
Outstanding Shares:
Purchase the Optipharm Co.,Ltd report to view the information.
Registered Capital:
Purchase the Optipharm Co.,Ltd report to view the information.
Financial Auditors:
Purchase the Optipharm Co.,Ltd report to view the information.
Incorporation Date:
July 27, 2000
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
31.5%
Purchase this report to view the information.
4.2%
Purchase this report to view the information.
2.8%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
(주)마니커
(주)마니커에프앤지
(주)우리에프앤지
Company Performance
Financial values in the chart are available after Optipharm Co.,Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
10.33%
Total operating revenue
1.68%
Operating profit (EBIT)
13.96%
EBITDA
30.65%
Net Profit (Loss) for the Period
9.17%
Total assets
-2.76%
Total equity
-13.26%
Operating Profit Margin (ROS)
5.66%
Net Profit Margin
4.15%
Return on Equity (ROE)
-0.15%
Debt to Equity Ratio
16.17%
Quick Ratio
-0.32%
Cash Ratio
0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?